Orient EuroPharma Co., Ltd. (TPEX:4120)
44.50
-0.20 (-0.45%)
At close: Dec 3, 2025
Orient EuroPharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,891 | 4,181 | 3,374 | 3,140 | 3,153 | 4,173 | Upgrade
|
| Market Cap Growth | -10.66% | 23.91% | 7.46% | -0.41% | -24.43% | -13.49% | Upgrade
|
| Enterprise Value | 5,723 | 8,267 | 7,274 | 6,427 | 5,292 | 5,012 | Upgrade
|
| Last Close Price | 44.85 | 47.35 | 37.45 | 34.85 | 34.12 | 43.48 | Upgrade
|
| PE Ratio | - | - | 23.44 | - | 26.24 | 20.94 | Upgrade
|
| PS Ratio | 0.86 | 0.95 | 0.74 | 0.66 | 0.66 | 0.78 | Upgrade
|
| PB Ratio | 0.49 | 0.72 | 0.81 | 0.91 | 0.91 | 1.07 | Upgrade
|
| P/TBV Ratio | 0.57 | 0.82 | 0.97 | 1.09 | 1.10 | 1.34 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 11.10 | Upgrade
|
| P/OCF Ratio | - | - | 52.18 | - | 40.61 | 6.86 | Upgrade
|
| EV/Sales Ratio | 1.26 | 1.88 | 1.58 | 1.36 | 1.11 | 0.93 | Upgrade
|
| EV/EBITDA Ratio | 151.53 | 53.87 | 30.85 | 913.23 | 87.72 | 18.01 | Upgrade
|
| EV/EBIT Ratio | - | - | 103.01 | - | - | 42.71 | Upgrade
|
| EV/FCF Ratio | -25.05 | - | - | - | - | 13.34 | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.73 | 1.16 | 1.46 | 1.22 | 0.62 | Upgrade
|
| Debt / EBITDA Ratio | 30.73 | 21.15 | 16.88 | 112.21 | 44.25 | 7.65 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 6.40 | Upgrade
|
| Asset Turnover | 0.37 | 0.39 | 0.43 | 0.48 | 0.54 | 0.67 | Upgrade
|
| Inventory Turnover | 2.03 | 2.10 | 2.00 | 2.26 | 2.15 | 2.10 | Upgrade
|
| Quick Ratio | 1.10 | 0.75 | 0.73 | 0.69 | 0.82 | 1.18 | Upgrade
|
| Current Ratio | 1.65 | 1.20 | 1.14 | 1.10 | 1.22 | 1.78 | Upgrade
|
| Return on Equity (ROE) | -5.86% | -4.63% | 4.45% | -8.57% | 2.02% | 2.77% | Upgrade
|
| Return on Assets (ROA) | -0.52% | -0.04% | 0.42% | -0.94% | -0.68% | 0.92% | Upgrade
|
| Return on Capital (ROIC) | -0.60% | -0.04% | 0.51% | -1.16% | -0.85% | 1.19% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.10% | -0.10% | 1.00% | -2.30% | -1.60% | 2.00% | Upgrade
|
| Earnings Yield | -11.91% | -6.79% | 4.27% | -9.90% | 3.81% | 4.78% | Upgrade
|
| FCF Yield | -5.87% | -5.27% | -1.03% | -27.32% | -47.10% | 9.01% | Upgrade
|
| Dividend Yield | 2.23% | 2.11% | 2.67% | - | 2.49% | 3.45% | Upgrade
|
| Payout Ratio | - | - | - | - | 108.28% | 78.35% | Upgrade
|
| Buyback Yield / Dilution | 0.23% | 0.23% | -0.23% | 0.24% | 0.21% | -0.07% | Upgrade
|
| Total Shareholder Return | 2.48% | 2.34% | 2.44% | 0.24% | 2.70% | 3.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.